UniProt ID | VPP2_HUMAN | |
---|---|---|
UniProt AC | Q9Y487 | |
Protein Name | V-type proton ATPase 116 kDa subunit a isoform 2 | |
Gene Name | ATP6V0A2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 856 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein. Endosome membrane. In kidney proximal tubules, also detected in subapical vesicles.. |
|
Protein Description | Part of the proton channel of V-ATPases. Essential component of the endosomal pH-sensing machinery. May play a role in maintaining the Golgi functions, such as glycosylation maturation, by controlling the Golgi pH. In aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of Fe(2+) prolyl hydroxylase (PHD) enzymes, and leading to HIF1A hydroxylation and subsequent proteasomal degradation. [PubMed: 28296633] | |
Protein Sequence | MGSLFRSETMCLAQLFLQSGTAYECLSALGEKGLVQFRDLNQNVSSFQRKFVGEVKRCEELERILVYLVQEINRADIPLPEGEASPPAPPLKQVLEMQEQLQKLEVELREVTKNKEKLRKNLLELIEYTHMLRVTKTFVKRNVEFEPTYEEFPSLESDSLLDYSCMQRLGAKLGFVSGLINQGKVEAFEKMLWRVCKGYTIVSYAELDESLEDPETGEVIKWYVFLISFWGEQIGHKVKKICDCYHCHVYPYPNTAEERREIQEGLNTRIQDLYTVLHKTEDYLRQVLCKAAESVYSRVIQVKKMKAIYHMLNMCSFDVTNKCLIAEVWCPEADLQDLRRALEEGSRESGATIPSFMNIIPTKETPPTRIRTNKFTEGFQNIVDAYGVGSYREVNPALFTIITFPFLFAVMFGDFGHGFVMFLFALLLVLNENHPRLNQSQEIMRMFFNGRYILLLMGLFSVYTGLIYNDCFSKSVNLFGSGWNVSAMYSSSHPPAEHKKMVLWNDSVVRHNSILQLDPSIPGVFRGPYPLGIDPIWNLATNRLTFLNSFKMKMSVILGIIHMTFGVILGIFNHLHFRKKFNIYLVSIPELLFMLCIFGYLIFMIFYKWLVFSAETSRVAPSILIEFINMFLFPASKTSGLYTGQEYVQRVLLVVTALSVPVLFLGKPLFLLWLHNGRSCFGVNRSGYTLIRKDSEEEVSLLGSQDIEEGNHQVEDGCREMACEEFNFGEILMTQVIHSIEYCLGCISNTASYLRLWALSLAHAQLSDVLWAMLMRVGLRVDTTYGVLLLLPVIALFAVLTIFILLIMEGLSAFLHAIRLHWVEFQNKFYVGAGTKFVPFSFSLLSSKFNNDDSVA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
92 | Ubiquitination | SPPAPPLKQVLEMQE CCCCCCHHHHHHHHH | 44.10 | 21963094 | |
103 | Ubiquitination | EMQEQLQKLEVELRE HHHHHHHHHHHHHHH | 56.03 | 32015554 | |
115 | Acetylation | LREVTKNKEKLRKNL HHHHHCCHHHHHHHH | 58.75 | 7708601 | |
115 | Ubiquitination | LREVTKNKEKLRKNL HHHHHCCHHHHHHHH | 58.75 | 24816145 | |
128 | Phosphorylation | NLLELIEYTHMLRVT HHHHHHHHHHHHHHH | 8.58 | 21406692 | |
129 | Phosphorylation | LLELIEYTHMLRVTK HHHHHHHHHHHHHHH | 6.50 | 21406692 | |
135 | Phosphorylation | YTHMLRVTKTFVKRN HHHHHHHHHHHHHCC | 20.24 | 21406692 | |
136 | Ubiquitination | THMLRVTKTFVKRNV HHHHHHHHHHHHCCC | 36.79 | 33845483 | |
148 | Phosphorylation | RNVEFEPTYEEFPSL CCCCCCCCHHHCCCC | 36.05 | 25841592 | |
149 | Phosphorylation | NVEFEPTYEEFPSLE CCCCCCCHHHCCCCC | 24.95 | 22817900 | |
154 | Phosphorylation | PTYEEFPSLESDSLL CCHHHCCCCCCCCHH | 50.52 | 22199227 | |
157 | Phosphorylation | EEFPSLESDSLLDYS HHCCCCCCCCHHCHH | 37.48 | 22199227 | |
159 | Phosphorylation | FPSLESDSLLDYSCM CCCCCCCCHHCHHHH | 39.86 | 22199227 | |
163 | Phosphorylation | ESDSLLDYSCMQRLG CCCCHHCHHHHHHHH | 12.07 | 22817900 | |
172 | Ubiquitination | CMQRLGAKLGFVSGL HHHHHHCHHHHHHHH | 47.55 | 23000965 | |
177 | Phosphorylation | GAKLGFVSGLINQGK HCHHHHHHHHCCCCH | 26.14 | 22817900 | |
223 | Phosphorylation | TGEVIKWYVFLISFW CHHHHHHHHHHHHHH | 4.02 | - | |
279 | Ubiquitination | DLYTVLHKTEDYLRQ HHHHHHHHCHHHHHH | 49.82 | 21963094 | |
279 | Acetylation | DLYTVLHKTEDYLRQ HHHHHHHHCHHHHHH | 49.82 | 19608861 | |
290 | Ubiquitination | YLRQVLCKAAESVYS HHHHHHHHHHHHHHH | 46.61 | 33845483 | |
320 | Phosphorylation | NMCSFDVTNKCLIAE HHCCCCCCCCEEEEE | 30.70 | 29759185 | |
349 | Phosphorylation | LEEGSRESGATIPSF HHHCCCCCCCCCCCH | 32.39 | 18452278 | |
352 | Phosphorylation | GSRESGATIPSFMNI CCCCCCCCCCCHHHC | 36.63 | 18452278 | |
355 | Phosphorylation | ESGATIPSFMNIIPT CCCCCCCCHHHCCCC | 33.02 | 18452278 | |
363 | Ubiquitination | FMNIIPTKETPPTRI HHHCCCCCCCCCCCC | 54.99 | 22817900 | |
374 | Ubiquitination | PTRIRTNKFTEGFQN CCCCCCCCCCHHHHH | 53.72 | 21890473 | |
484 | N-linked_Glycosylation | NLFGSGWNVSAMYSS EECCCCCCHHHHHCC | 22.76 | UniProtKB CARBOHYD | |
490 | Phosphorylation | WNVSAMYSSSHPPAE CCHHHHHCCCCCCHH | 16.57 | - | |
491 | Phosphorylation | NVSAMYSSSHPPAEH CHHHHHCCCCCCHHH | 18.38 | - | |
492 | Phosphorylation | VSAMYSSSHPPAEHK HHHHHCCCCCCHHHC | 33.79 | - | |
505 | N-linked_Glycosylation | HKKMVLWNDSVVRHN HCCEEEECCHHHCCC | 27.76 | UniProtKB CARBOHYD | |
507 | Phosphorylation | KMVLWNDSVVRHNSI CEEEECCHHHCCCHH | 21.21 | - | |
529 | Phosphorylation | PGVFRGPYPLGIDPI CCCCCCCCCCCCCCH | 17.57 | 22210691 | |
541 | Phosphorylation | DPIWNLATNRLTFLN CCHHHHHCCCHHHHH | 24.84 | 22210691 | |
549 | Phosphorylation | NRLTFLNSFKMKMSV CCHHHHHHHHHHHHH | 28.52 | 22210691 | |
680 | S-palmitoylation | WLHNGRSCFGVNRSG EECCCCCCCCCCCCC | 3.11 | 29575903 | |
686 | Phosphorylation | SCFGVNRSGYTLIRK CCCCCCCCCCEEEEC | 30.83 | 28152594 | |
688 | Phosphorylation | FGVNRSGYTLIRKDS CCCCCCCCEEEECCC | 10.30 | 28152594 | |
689 | Phosphorylation | GVNRSGYTLIRKDSE CCCCCCCEEEECCCH | 21.16 | 28152594 | |
693 | Ubiquitination | SGYTLIRKDSEEEVS CCCEEEECCCHHHHH | 59.62 | - | |
695 | Phosphorylation | YTLIRKDSEEEVSLL CEEEECCCHHHHHHH | 50.36 | 29255136 | |
700 | Phosphorylation | KDSEEEVSLLGSQDI CCCHHHHHHHCCCCC | 22.58 | 30266825 | |
704 | Phosphorylation | EEVSLLGSQDIEEGN HHHHHHCCCCCCCCC | 25.34 | 17525332 | |
841 | Phosphorylation | GTKFVPFSFSLLSSK CCCCEEEEHHHHHHH | 14.09 | 30622161 | |
843 | Phosphorylation | KFVPFSFSLLSSKFN CCEEEEHHHHHHHCC | 27.48 | 30622161 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VPP2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VPP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VPP2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LAMP2_HUMAN | LAMP2 | physical | 27244671 | |
VA0D2_HUMAN | ATP6V0D2 | physical | 28514442 | |
K2013_HUMAN | KIAA2013 | physical | 28514442 | |
TMCC3_HUMAN | TMCC3 | physical | 28514442 | |
CLCN6_HUMAN | CLCN6 | physical | 28514442 | |
SPRY7_HUMAN | SPRYD7 | physical | 28514442 | |
CC115_HUMAN | CCDC115 | physical | 28514442 | |
VATC1_HUMAN | ATP6V1C1 | physical | 28514442 | |
VATD_HUMAN | ATP6V1D | physical | 28514442 | |
VMA21_HUMAN | VMA21 | physical | 28514442 | |
VPP1_HUMAN | ATP6V0A1 | physical | 28514442 | |
VATE1_HUMAN | ATP6V1E1 | physical | 28514442 | |
VAS1_HUMAN | ATP6AP1 | physical | 28514442 | |
ANKL2_HUMAN | ANKLE2 | physical | 28514442 | |
VATB2_HUMAN | ATP6V1B2 | physical | 28514442 | |
CSCL2_HUMAN | TMEM63B | physical | 28514442 | |
PMGT1_HUMAN | POMGNT1 | physical | 28514442 | |
VATF_HUMAN | ATP6V1F | physical | 28514442 | |
ANXA6_HUMAN | ANXA6 | physical | 28514442 | |
AT11C_HUMAN | ATP11C | physical | 28514442 | |
B4GT3_HUMAN | B4GALT3 | physical | 28514442 | |
PPAL_HUMAN | ACP2 | physical | 28514442 | |
AT5F1_HUMAN | ATP5F1 | physical | 28514442 | |
TYW1_HUMAN | TYW1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00557 | Cutis laxa, including: Autosomal dominant cutis laxa (ADCL); Autosomal recessive cutis laxa I (ARCL1 | |||||
OMIM Disease | ||||||
219200 | Cutis laxa, autosomal recessive, 2A (ARCL2A) | |||||
278250 | Wrinkly skin syndrome (WSS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-279, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-695; SER-700 ANDSER-704, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-695 AND SER-704, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177 AND SER-695, ANDMASS SPECTROMETRY. |